# Journey Medical Corp: filings

DERM · Nasdaq · CIK 1867066 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/derm.md) · [Financials](/companies/derm/financials.md) · [Filings](/companies/derm/filings.md) · [Insiders](/companies/derm/insiders.md)

## Reports and events: 78 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 74, 8-K 48, 10-Q 15, 3 10, UPLOAD 9, CORRESP 8, SCHEDULE 13G/A 6, 10-K 5, 424B3 5, DEF 14A 5, DEFA14A 5, S-1/A 4, S-8 4, EFFECT 3, DRS 2, DRS/A 2, DRSLTR 2, S-3 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 3/A 1, 424B5 1, 4/A 1, 8-A12B 1, CERT 1, D 1, D/A 1, NT 10-Q 1, PRE 14A 1, S-1 1, SC 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 20:40 ET | [10-Q](/filings/0001104659-26-094948.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094948 |
| 2026-08-12 | 20:05 ET | [8-K](/filings/0001104659-26-094862.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094862 |
| 2026-06-26 | 00:01 ET | [8-K](/filings/0001104659-26-077888.md) | 5.07 Shareholder vote results | 0001104659-26-077888 |
| 2026-05-13 | 20:33 ET | [10-Q](/filings/0001104659-26-060297.md) | Quarterly report, period 2026-03-31 | 0001104659-26-060297 |
| 2026-05-13 | 20:06 ET | [8-K](/filings/0001104659-26-060232.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-060232 |
| 2026-04-30 | 20:06 ET | [DEF 14A](/filings/0001104659-26-052883.md) | Proxy statement, period 2026-06-24 | 0001104659-26-052883 |
| 2026-04-21 | 21:20 ET | [8-K](/filings/0001104659-26-046158.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-046158 |
| 2026-03-26 | 21:35 ET | [10-K](/filings/0001104659-26-034629.md) | Annual report, period 2025-12-31 | 0001104659-26-034629 |
| 2026-03-25 | 20:05 ET | [8-K](/filings/0001104659-26-034506.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-034506 |
| 2025-11-12 | 21:41 ET | [10-Q](/filings/0001104659-25-110457.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110457 |
| 2025-11-12 | 21:07 ET | [8-K](/filings/0001104659-25-110344.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110344 |
| 2025-09-26 | 20:39 ET | [8-K](/filings/0001104659-25-093891.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-25-093891 |
| 2025-08-28 | 21:30 ET | [8-K](/filings/0001104659-25-084879.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-084879 |
| 2025-08-12 | 20:36 ET | [10-Q](/filings/0001410578-25-001703.md) | Quarterly report, period 2025-06-30 | 0001410578-25-001703 |
| 2025-08-12 | 20:05 ET | [8-K](/filings/0001104659-25-076825.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-076825 |
| 2025-07-14 | 20:50 ET | [8-K](/filings/0001104659-25-067767.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-067767 |
| 2025-06-26 | 20:05 ET | [8-K](/filings/0001104659-25-063032.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-063032 |
| 2025-06-24 | 12:30 ET | [8-K](/filings/0001104659-25-061956.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-061956 |
| 2025-05-15 | 10:01 ET | [10-Q](/filings/0001410578-25-001296.md) | Quarterly report, period 2025-03-31 | 0001410578-25-001296 |
| 2025-05-14 | 20:05 ET | [8-K](/filings/0001104659-25-048502.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-048502 |
| 2025-04-29 | 20:06 ET | [DEF 14A](/filings/0001104659-25-041214.md) | Proxy statement, period 2025-06-24 | 0001104659-25-041214 |
| 2025-04-03 | 11:31 ET | [8-K](/filings/0001104659-25-031463.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-031463 |
| 2025-03-27 | 01:47 ET | [10-K](/filings/0001410578-25-000490.md) | Annual report, period 2024-12-31 | 0001410578-25-000490 |
| 2025-03-26 | 20:06 ET | [8-K](/filings/0001104659-25-028226.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-028226 |
| 2025-03-24 | 12:30 ET | [8-K](/filings/0001104659-25-026878.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-026878 |
| 2025-02-05 | 21:01 ET | [8-K](/filings/0001104659-25-009641.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-009641 |
| 2024-11-12 | 21:06 ET | [10-Q](/filings/0001410578-24-001877.md) | Quarterly report, period 2024-09-30 | 0001410578-24-001877 |
| 2024-11-12 | 21:05 ET | [8-K](/filings/0001104659-24-116762.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-116762 |
| 2024-11-04 | 12:30 ET | [8-K](/filings/0001104659-24-113659.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-113659 |
| 2024-08-13 | 22:21 ET | [10-Q](/filings/0001410578-24-001326.md) | Quarterly report, period 2024-06-30 | 0001410578-24-001326 |
| 2024-08-12 | 20:08 ET | [8-K](/filings/0001104659-24-088345.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-088345 |
| 2024-07-12 | 21:14 ET | [8-K](/filings/0001104659-24-079596.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors | 0001104659-24-079596 |
| 2024-06-25 | 20:06 ET | [8-K](/filings/0001104659-24-074743.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-074743 |
| 2024-05-14 | 20:46 ET | [10-Q](/filings/0001410578-24-000817.md) | Quarterly report, period 2024-03-31 | 0001410578-24-000817 |
| 2024-05-13 | 20:05 ET | [8-K](/filings/0001104659-24-060513.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-060513 |
| 2024-05-01 | 20:05 ET | [8-K](/filings/0001104659-24-055725.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-055725 |
| 2024-04-29 | 20:06 ET | [DEF 14A](/filings/0001104659-24-054010.md) | Proxy statement, period 2024-06-25 | 0001104659-24-054010 |
| 2024-03-29 | 01:01 ET | [10-K](/filings/0001410578-24-000347.md) | Annual report, period 2023-12-31 | 0001410578-24-000347 |
| 2024-03-21 | 20:20 ET | [8-K](/filings/0001104659-24-037318.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-037318 |
| 2024-01-02 | 21:05 ET | [8-K](/filings/0001104659-24-000325.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-000325 |
| 2023-12-08 | 22:01 ET | [8-K](/filings/0001104659-23-124742.md) | 5.02 Departure or appointment of officers or directors | 0001104659-23-124742 |
| 2023-11-13 | 00:55 ET | [10-Q](/filings/0001410578-23-002335.md) | Quarterly report, period 2023-09-30 | 0001410578-23-002335 |
| 2023-11-07 | 21:45 ET | [8-K](/filings/0001104659-23-115285.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-115285 |
| 2023-09-26 | 13:10 ET | [8-K](/filings/0001104659-23-103747.md) | 8.01 Other events | 0001104659-23-103747 |
| 2023-09-19 | 20:59 ET | [8-K](/filings/0001104659-23-101975.md) | 8.01 Other events | 0001104659-23-101975 |
| 2023-09-06 | 12:00 ET | [8-K](/filings/0001104659-23-098505.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-098505 |
| 2023-08-18 | 21:00 ET | [8-K](/filings/0001104659-23-093537.md) | 3.01 Delisting notice | 0001104659-23-093537 |
| 2023-08-10 | 20:45 ET | [10-Q](/filings/0001410578-23-001702.md) | Quarterly report, period 2023-06-30 | 0001410578-23-001702 |
| 2023-08-08 | 20:06 ET | [8-K](/filings/0001104659-23-088823.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-088823 |
| 2023-07-26 | 12:30 ET | [8-K](/filings/0001104659-23-084082.md) | 8.01 Other events | 0001104659-23-084082 |

Page 1 of 2. [Older](/companies/derm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.